Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeZavation Medical Products, LLCZavation Medical Products, LLC. Launches Titanium/PEEK Posterior LEIF Cage Designed for Use in the Lumbar Spine as a Spinal Fusion Procedure

Zavation Medical Products, LLC. Launches Titanium/PEEK Posterior LEIF Cage Designed for Use in the Lumbar Spine as a Spinal Fusion Procedure

Titanium/PEEK Posterior LEIF (Lateral Expandable Interbody Fusion) cage, a cage designed for use in the lumbar spine as a spinal fusion procedure has been launched by Zavation Medical Products.

The Titanium/PEEK Posterior LEIF cage is the latest addition to Zavation’s portfolio. The cage is designed to provide structural stability in a shape that accommodates a posterior or transforaminal approach to the lumbar spine. It is available in various heights and geometric options to fit the anatomical needs of a wide variety of patients. After insertion, the implant can be expanded to a larger footprint which doubles the graft volume, and it can then be filled with autogenous bone graft material through the inserter.

Dr. Jimmy Miller, Neurosurgeon at Greenwood LeFlore Hospital, stated, “There are several very important advantages of the hybrid LEIF cage. First, the expanded cage has a large size that lessens the likelihood of subsidence. Second, it has a large footprint and an increased available space for graft material that promotes bony fusion. Third, once expanded the hybrid LEIF cage is wider than the annulotomy through which it was inserted, lessening the possibility of posterior migration. Fourth, it has the increased strength of a titanium alloy.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy